Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Radius Recycling | RDUS | Jan 17, 2025 | 12.74 | +5.38 |
RadNet | RDNT | Jan 17, 2025 | 59.86 | -1.68 |
Radware | RDWR | Jan 17, 2025 | 21.83 | +0.37 |
Rafael B | RFL | Jan 17, 2025 | 2.01 | +0.50 |
Rail Vision | RVSN | Jan 17, 2025 | 1.09 | -5.22 |
Rallybio | RLYB | Jan 17, 2025 | 0.88 | -1.65 |
Ralph Lauren | RL | Jan 17, 2025 | 240.46 | +1.15 |
Ramaco Resources A | METC | Jan 17, 2025 | 9.58 | +3.68 |
Ramaco Resources B | METCB | Jan 17, 2025 | 9.11 | +0.44 |
Rambus | RMBS | Jan 17, 2025 | 61.92 | +3.77 |
Rand Capital | RAND | Jan 17, 2025 | 21.68 | +1.16 |
Range Capital Acquisition | RANG | Jan 17, 2025 | 9.94 | 0.00 |
Range Capital Acquisition Unit | RANGU | Jan 17, 2025 | 10.11 | 0.00 |
Range Resources | RRC | Jan 17, 2025 | 41.07 | -0.53 |
Ranger Energy Services A | RNGR | Jan 17, 2025 | 17.59 | -0.17 |
Rani Therapeutics A | RANI | Jan 17, 2025 | 1.31 | -0.76 |
Ranpak A | PACK | Jan 17, 2025 | 6.37 | +0.79 |
Rapid Micro Biosystems A | RPID | Jan 17, 2025 | 1.23 | +2.50 |
Rapid7 | RPD | Jan 17, 2025 | 38.84 | -2.39 |
Rapport Therapeutics | RAPP | Jan 17, 2025 | 12.69 | +1.44 |
RAPT Therapeutics | RAPT | Jan 17, 2025 | 1.20 | +0.84 |
Rare Earth/Str Metals ETF Market Vectors | REMX | Jan 17, 2025 | 42.84 | +1.04 |
Rave Restaurant Group | RAVE | Jan 17, 2025 | 2.62 | +0.38 |
Raymond James Financial | RJF | Jan 17, 2025 | 167.01 | +1.28 |
Raymond James Financial B | RJF-B | Jan 17, 2025 | 25.22 | +0.12 |
Rayonier Advanced Materials | RYAM | Jan 17, 2025 | 7.53 | -1.44 |
Rayonier REIT | RYN | Jan 17, 2025 | 26.52 | +1.34 |
Raytech Holding | RAY | Jan 17, 2025 | 1.20 | -2.44 |
RB Global | RBA | Jan 17, 2025 | 89.25 | -0.66 |
RBB Bancorp | RBB | Jan 17, 2025 | 20.09 | +0.15 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.